Trial intelligence / Profile preview

Total Glucosides of Paeony Combined With Acitretin Capsules to Treat Psoriasis Vulgaris

NCT02191020Completed

Sponsor
Xijing Hospital
Start
Feb 2013
Primary completion
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of total glucosides of paeony in Psoriasis vulgaris (PV) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Reduction in Psoriasis Area and Severity Index at 12 weeks. Started Feb 2013; status: completed.

02

Drugs

total glucosides of paeony
03

Conditions

Psoriasis vulgaris (PV)

Beyond the preview

Go deeper on NCT02191020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02191020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call